SuperworthFilana Therapeutics shares outstanding FLNA
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Dec 31, 2025
- 48.3M
- On a year earlier
- +0.4%
- more shares
Filana Therapeutics had 48.3M diluted shares outstanding on average in Q4 FY25, the quarter to Dec 31, 2025.
That is about the same as a year earlier.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 48.3M | +0% |
| FY2024 | 48.1M | +14% |
| FY2023 | 42.2M | +6% |
| FY2021 | 40M | +33% |
| FY2020 | 30.2M | +66% |
| FY2019 | 18.2M | +6% |
| FY2018 | 17.2M | +163% |
| FY2017 | 6.5M | +0% |
| FY2016 | 6.5M | −3% |
| FY2015 | 6.7M | +4% |
| FY2014 | 6.5M | +0% |
| FY2013 | 6.5M | +1% |
| FY2012 | 6.4M | +1% |
| FY2011 | 6.4M | +4% |
| FY2010 | 6.1M | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q4 FY25 | 48.3M | +0% | |
| Q3 FY25 | 48.3M | +1% | |
| Q2 FY25 | 48.3M | +5% | |
| Q1 FY25 | 48.3M | +9% | |
| Q4 FY24 | 48.1M | +14% | |
| Q3 FY24 | 48M | +14% | |
| Q2 FY24 | 46.2M | +11% | |
| Q1 FY24 | 44.1M | +6% | |
| Q4 FY23 | 42.2M | n/a | |
| Q3 FY23 | 42M | n/a | |
| Q2 FY23 | 41.8M | +4% | |
| Q1 FY23 | 41.7M | +4% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Filana Therapeutics
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.